Notice of Proposed Sale · 144
RxSight, Inc.
RXSTNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- RxSight, Inc.
- Issuer CIK
- 0001111485
- SEC file number
- 001-40690
- Phone
- 949-521-7822
- Person for whose account securities are to be sold
- Kurtz Ronald M MD
- Relationships to issuer
- Officer
- Street
- 100 COLUMBIA STREET
- Street (continued)
- SUITE 120
- City
- ALISO VIEJO
- State / country code
- CA
- Postal code
- 92656
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common Stock | 5,100 | 35,496.00 | 41,593,256 | 09/02/2026 | NASDAQ | E-Trade Financial Corporation |
Broker / market maker — proposed row 1, entry 1
- Name
- E-Trade Financial Corporation
- Street
- 3 Edison Drive
- City
- Alpharetta
- State / country code
- GA
- Postal code
- 30005
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common Stock | 08/31/2026 | Restricted Stock Units | Issuer | 13,425 | N | 08/31/2026 | N/A |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Remarks
Shares to be sold to cover withholding taxes upon vesting of restricted stock unit awards
Notice signature
- Notice date
- 09/02/2026
- Signed
- /s/ Jim Schindler, as Attorney-in-Fact
Filed exhibits
- EX-24 ↗rkpoa.pdf
Company context
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL/LAL+, collectively the “LAL”), RxSight Light Delivery Device (LDD) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.